Principles of drug abuse liability assessment in laboratory animals.
about
Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyondMedications development for opioid abuseSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderMaternal environment influences cocaine intake in adulthood in a genotype-dependent mannerNicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Monoamine transporter inhibitors and substrates as treatments for stimulant abuseReducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment.Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel reportIn vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityEvaluation of prescription opioids using operant-based pain measures in rats.Intracranial self-stimulation to evaluate abuse potential of drugs.Social influences on morphine sensitization in adolescent females.Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendationsProlonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeysThe Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research.Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.Tolerance to the rate-increasing and not rate-decreasing effects of pregnanolone in ratsWilliam L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.How research in behavioral pharmacology informs behavioral science.Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboonsPharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature.Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023Different lengths of times for progressions in adolescent substance involvement.Principles of laboratory assessment of drug abuse liability and implications for clinical development.Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeysOperant self-administration of sweetened ethanol and time course of blood ethanol levels in adolescent and adult male Long-Evans ratsDiscriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained ratsPatterns of nicotinic receptor antagonism: nicotine discrimination studies.The discriminative stimulus effects of midazolam are resistant to modulation by morphine, amphetamine, dizocilpine, and γ-butyrolactone in rhesus monkeysThe utility of animal models to evaluate novel anti-obesity agents.Behavioral mechanisms underlying nicotine reinforcement.Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans ratsThe reinforcement threshold for nicotine as a target for tobacco control.Usual energy intake mediates the relationship between food reinforcement and BMI.Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsAssessment of the interoceptive effects of alcohol in rats using short-term training procedures.Food reinforcement and eating: a multilevel analysis.Age-dependent morphine intake and cue-induced reinstatement, but not escalation in intake, by adolescent and adult male ratsPreclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
P2860
Q24644809-2B6CDB2D-2A9D-4360-9B34-928019B30049Q26853370-B12AB997-079D-4D01-81F1-E11319DCE2CBQ27015917-6EA2108B-5058-4BBD-A900-24A1AEE5B009Q28472723-BB65D5B1-5F63-4E8D-940B-9B8D7F74F050Q30244252-8C9A0E6E-8A89-46A7-AEBB-2CB47BBC46BDQ30413718-2F035FF1-7EC6-416D-BE1A-04B82EDF5540Q33574884-7180D42A-AF70-4E3F-9D12-D49576ED4DBDQ33638031-6B1DB785-CB4A-4B9E-9BC0-616866536180Q33748353-F223D8C3-85DA-4E42-81FC-1C683CA3B080Q33751118-29C28962-072C-4F76-97A1-17DE60DE59D1Q33821443-93309B1A-90F8-43E9-BAB5-9164104996F1Q33845750-B8761567-2570-4D57-9CC8-D1F916E40437Q34157204-E4951F74-B4EC-4D43-9FCF-E1398065F2EAQ34225896-6B41998B-BCA6-41C9-9662-BEE32AC1EA40Q34423583-D37CDA24-A5C9-46BC-AD5C-83E6FF044277Q34462263-AA1C1216-FB75-40EF-9B8E-67E41A2D743CQ34536352-25A9E566-C03B-4E2F-803A-B270AFB19626Q34538484-2E1E3184-7537-4DCD-BDEF-6DB8F1C4B5A6Q34550795-4D5E20F3-30EE-4D17-8FB9-19F4202D837FQ34602728-72493B43-3452-4F1B-AFF6-156481643660Q34630587-CA423856-16E3-4DD6-8B24-13E3BCE046F2Q34687456-76814967-0875-4723-A955-0E29CA34B35FQ34768548-D33CCE6B-FCDE-4D11-A1DF-2183162373CDQ34928953-0FDA761A-BED2-48D4-9267-9A5F79A776DDQ34981070-CD5A2BFB-9281-475F-9413-7A317D114DA2Q35065338-EDD4F29A-F810-4CCA-BAFE-0C57782CFEE9Q35142973-0731AE9A-BDE3-4A98-BF27-B1621899B1A0Q35181608-12178A47-32D0-42CB-A6AF-829F752237E3Q35265699-14FC1EC1-BB32-45B9-B53D-5C9DCE1DCB4EQ35368248-836349AC-4FFE-4B55-82AE-D1242B8F66E6Q35589958-EAC19F86-F093-4EBC-B20C-50009D296A78Q35954791-192C79BC-02BC-4E19-9BCC-58C72CCC61DBQ36011614-319AAB13-DDCE-4FB3-B719-0DAB893E6338Q36164835-8D46021D-2793-4C6B-8970-50C1DD5CC620Q36192390-A7E9BD5E-6667-4144-8967-078E9C2C7BA6Q36389047-5869D304-AB88-4747-AC20-2D9016751148Q36395109-4B0CEC98-2C01-42B0-80F2-B8604A906FC8Q36416603-B6AF6918-FBE9-4D8E-92F0-B36E58526726Q36443878-3BD6B786-D7AD-4B4A-A473-7B2B4969672FQ36449558-D1C154E8-1DA4-4D1F-A43C-FB762F36BB9C
P2860
Principles of drug abuse liability assessment in laboratory animals.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Principles of drug abuse liability assessment in laboratory animals.
@ast
Principles of drug abuse liability assessment in laboratory animals.
@en
type
label
Principles of drug abuse liability assessment in laboratory animals.
@ast
Principles of drug abuse liability assessment in laboratory animals.
@en
prefLabel
Principles of drug abuse liability assessment in laboratory animals.
@ast
Principles of drug abuse liability assessment in laboratory animals.
@en
P1476
Principles of drug abuse liability assessment in laboratory animals.
@en
P2093
Nancy A Ator
Roland R Griffiths
P304
P356
10.1016/S0376-8716(03)00099-1
P433
P577
2003-06-01T00:00:00Z